Galvanize Therapeutics Funding: $200M Raised, Series C

Galvanize Therapeutics funding overview

Galvanize Therapeutics is a Biotech company based in San Carlos, CA. Galvanize Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2025. The round record for Galvanize Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors and 6 others. 12 distinct backers are named across the disclosed rounds.

Galvanize Therapeutics at a glance

Total raised: $200M
Latest round: Series C
Latest round date: September 2025
Industry: Biotech
Headquarters: San Carlos, CA
Notable investors: Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors, Longaeva, Fidelity Management & Research Company

Frequently asked about Galvanize Therapeutics funding

How much has Galvanize Therapeutics raised?: Galvanize Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Galvanize Therapeutics?: Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors are named among the investors backing Galvanize Therapeutics.
What was the latest Galvanize Therapeutics funding round?: The most recent disclosed round is a Series C, announced in September 2025.
Where is Galvanize Therapeutics based?: Galvanize Therapeutics is based in San Carlos, CA.
What sector does Galvanize Therapeutics operate in?: Galvanize Therapeutics is tracked under Biotech from San Carlos, CA, with $200M in disclosed funding.
When did Galvanize Therapeutics last raise?: The last disclosed Galvanize Therapeutics round closed in September 2025 at Series C.

Every Galvanize Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Carlos at a similar stage.

Galvanize Therapeutics Funding: $200M Raised, Series C

Galvanize Therapeutics funding overview

Galvanize Therapeutics at a glance

Frequently asked about Galvanize Therapeutics funding

Galvanize Therapeutics founders (1)

Companies related to Galvanize Therapeutics (40)

Browse related funding lists (8)